X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs558366-   
Low Rs362264-   
Sales per share (Unadj.) Rs116.3108.9-  
Earnings per share (Unadj.) Rs17.9-27.4-  
Cash flow per share (Unadj.) Rs23.1-22.7-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.485.5-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 136.6%   
Avg P/E ratio x25.7-11.5 -224.1%  
P/CF ratio (eoy) x19.9-13.9 -143.4%  
Price / Book Value ratio x5.43.7 146.0%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,66453,186 884.9%   
No. of employees `00011.84.3 275.3%   
Total wages/salary Rs m18,5453,338 555.6%   
Avg. sales/employee Rs Th10,072.74,281.9 235.2%   
Avg. wages/employee Rs Th1,569.1777.6 201.8%   
Avg. net profit/employee Rs Th1,547.7-1,078.9 -143.4%   
INCOME DATA
Net Sales Rs m119,04918,382 647.6%  
Other income Rs m1,132129 879.4%   
Total revenues Rs m120,18118,511 649.3%   
Gross profit Rs m28,475-3,185 -893.9%  
Depreciation Rs m5,388793 679.1%   
Interest Rs m911498 183.0%   
Profit before tax Rs m23,308-4,348 -536.1%   
Minority Interest Rs m628-12 -5,181.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644272 2,077.4%   
Profit after tax Rs m18,292-4,632 -394.9%  
Gross profit margin %23.9-17.3 -138.0%  
Effective tax rate %24.2-6.2 -387.5%   
Net profit margin %15.4-25.2 -61.0%  
BALANCE SHEET DATA
Current assets Rs m82,00513,463 609.1%   
Current liabilities Rs m60,7207,575 801.6%   
Net working cap to sales %17.932.0 55.8%  
Current ratio x1.41.8 76.0%  
Inventory Days Days73111 65.9%  
Debtors Days Days98124 79.3%  
Net fixed assets Rs m83,7037,848 1,066.6%   
Share capital Rs m1,02485 1,199.8%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,44514,428 606.1%   
Long term debt Rs m25,5515,070 503.9%   
Total assets Rs m180,65327,255 662.8%  
Interest coverage x26.6-7.7 -343.8%   
Debt to equity ratio x0.30.4 83.1%  
Sales to assets ratio x0.70.7 97.7%   
Return on assets %10.6-15.2 -70.1%  
Return on equity %20.9-32.1 -65.2%  
Return on capital %22.0-19.8 -111.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,1931,569 585.9%  
From Investments Rs m-9,737-482 2,021.1%  
From Financial Activity Rs m5154,602 11.2%  
Net Cashflow Rs m-295,689 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.05 Rs / ZAR

Compare CADILA HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: SANOFI INDIA  DISHMAN PHARMA  ALKEM LABORATORIES  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends 317 Points Higher; Realty and FMCG Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day on a strong note. Gains were largely seen in the realty sector and FMCG sector.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Up 274.4% (Quarterly Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

For the quarter ended June 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (up 274.4% YoY). Sales on the other hand came in at Rs 29 bn (up 29.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Nov 19, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS